chr1-216199789-C-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_206933.4(USH2A):c.3649G>A(p.Asp1217Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000155 in 1,613,996 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D1217G) has been classified as Uncertain significance.
Frequency
Consequence
NM_206933.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152186Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000797 AC: 2AN: 251080 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461810Hom.: 0 Cov.: 32 AF XY: 0.0000165 AC XY: 12AN XY: 727216 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152186Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74356 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Usher syndrome type 2A Uncertain:2
- -
- -
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The p.Asp1217Asn va riant in USH2A has not been previously reported in individuals with hearing loss , but has been identified in 1/66726 European chromosomes and 1/16512 South Asia n chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstit ute.org; dbSNP rs202247801). The aspartic acid (Asp) at position 1217 is not con served through species, with 2 mammals (gibbon and platypus) having an asparagin e (Asn) at this position. Additional computational prediction tools suggest that this variant may not impact the protein, though this information is not predict ive enough to rule out pathogenicity. In summary, while the clinical significanc e of the p.Asp1217Asn variant is uncertain, the lack of evolutionary conservatio n suggests that it is more likely to be benign. -
Usher syndrome type 2A;C3151138:Retinitis pigmentosa 39 Uncertain:1
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
not provided Uncertain:1
This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 1217 of the USH2A protein (p.Asp1217Asn). This variant is present in population databases (rs202247801, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with USH2A-related conditions. ClinVar contains an entry for this variant (Variation ID: 91896). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The asparagine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Retinitis pigmentosa 39 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at